Zhou D - Search Results

1

Author Correction: An engineered influenza virus to deliver antigens for lung cancer vaccination.

Ji D, Zhang Y, Sun J, Zhang B, Ma W, Cheng B, Wang X, Li Y, Mu Y, Xu H, Wang Q, Zhang C, Xiao S, Zhang L, Zhou D. Ji D, et al. Among authors: zhou d. Nat Biotechnol. 2024 Mar;42(3):529. doi: 10.1038/s41587-023-01884-8. Nat Biotechnol. 2024. PMID: 37443392 No abstract available.

2

Strand antagonism in RNAi: an explanation of differences in potency between intracellularly expressed siRNA and shRNA.

Jin X, Sun T, Zhao C, Zheng Y, Zhang Y, Cai W, He Q, Taira K, Zhang L, Zhou D. Jin X, et al. Among authors: zhou d. Nucleic Acids Res. 2012 Feb;40(4):1797-806. doi: 10.1093/nar/gkr927. Epub 2011 Oct 28. Nucleic Acids Res. 2012. PMID: 22039150 Free PMC article.

3

Conjugation of cyclodextrin with fullerene as a new class of HCV entry inhibitors.

Xiao SL, Wang Q, Yu F, Peng YY, Yang M, Sollogoub M, Sinaÿ P, Zhang YM, Zhang LH, Zhou DM. Xiao SL, et al. Bioorg Med Chem. 2012 Sep 15;20(18):5616-22. doi: 10.1016/j.bmc.2012.07.029. Epub 2012 Jul 23. Bioorg Med Chem. 2012. PMID: 22884577

4

Elucidation of the pharmacophore of echinocystic acid, a new lead for blocking HCV entry.

Wang H, Wang Q, Xiao SL, Yu F, Ye M, Zheng YX, Zhao CK, Sun DA, Zhang LH, Zhou DM. Wang H, et al. Eur J Med Chem. 2013 Jun;64:160-8. doi: 10.1016/j.ejmech.2013.03.041. Epub 2013 Apr 3. Eur J Med Chem. 2013. PMID: 23644199

5

Development of oleanane-type triterpenes as a new class of HCV entry inhibitors.

Yu F, Wang Q, Zhang Z, Peng Y, Qiu Y, Shi Y, Zheng Y, Xiao S, Wang H, Huang X, Zhu L, Chen K, Zhao C, Zhang C, Yu M, Sun D, Zhang L, Zhou D. Yu F, et al. Among authors: zhou d. J Med Chem. 2013 Jun 13;56(11):4300-19. doi: 10.1021/jm301910a. Epub 2013 May 28. J Med Chem. 2013. PMID: 23662817

6

Synthesis and anti-HCV entry activity studies of β-cyclodextrin-pentacyclic triterpene conjugates.

Xiao S, Wang Q, Si L, Shi Y, Wang H, Yu F, Zhang Y, Li Y, Zheng Y, Zhang C, Wang C, Zhang L, Zhou D. Xiao S, et al. Among authors: zhou d. ChemMedChem. 2014 May;9(5):1060-70. doi: 10.1002/cmdc.201300545. Epub 2014 Mar 12. ChemMedChem. 2014. PMID: 24623716

7

Development of bivalent oleanane-type triterpenes as potent HCV entry inhibitors.

Yu F, Peng Y, Wang Q, Shi Y, Si L, Wang H, Zheng Y, Lee E, Xiao S, Yu M, Li Y, Zhang C, Tang H, Wang C, Zhang L, Zhou D. Yu F, et al. Among authors: zhou d. Eur J Med Chem. 2014 Apr 22;77:258-68. doi: 10.1016/j.ejmech.2014.03.017. Epub 2014 Mar 7. Eur J Med Chem. 2014. PMID: 24650713

8

Discovery of pentacyclic triterpenoids as potential entry inhibitors of influenza viruses.

Yu M, Si L, Wang Y, Wu Y, Yu F, Jiao P, Shi Y, Wang H, Xiao S, Fu G, Tian K, Wang Y, Guo Z, Ye X, Zhang L, Zhou D. Yu M, et al. Among authors: zhou d. J Med Chem. 2014 Dec 11;57(23):10058-71. doi: 10.1021/jm5014067. Epub 2014 Nov 21. J Med Chem. 2014. PMID: 25383779

9

Elevated expression of AKR1C3 increases resistance of cancer cells to ionizing radiation via modulation of oxidative stress.

Xiong W, Zhao J, Yu H, Li X, Sun S, Li Y, Xia Q, Zhang C, He Q, Gao X, Zhang L, Zhou D. Xiong W, et al. Among authors: zhou d. PLoS One. 2014 Nov 24;9(11):e111911. doi: 10.1371/journal.pone.0111911. eCollection 2014. PLoS One. 2014. PMID: 25419901 Free PMC article.

10

c-Met targeting enhances the effect of irradiation and chemical agents against malignant colon cells harboring a KRAS mutation.

Li Y, Wang J, Gao X, Han W, Zheng Y, Xu H, Zhang C, He Q, Zhang L, Li Z, Zhou D. Li Y, et al. Among authors: zhou d. PLoS One. 2014 Nov 26;9(11):e113186. doi: 10.1371/journal.pone.0113186. eCollection 2014. PLoS One. 2014. PMID: 25427200 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

13,269 results

Search Page

Filters